HIV vaccine vCP1521 (Sanofi Pasteur)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHIV vaccine vCP1521 (Sanofi Pasteur)
Drug Alias NameAventis Pasteur live recombinant ALVAC-HIV (vCP1521) priming vaccine + VaxGen gp120 B/E (AIDSVAX B/E) boosting vaccinevCP1521ALVAC-HIV-vCP1521
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUganda
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A